This inventor holds 18 USPTO granted patents and 11 published patent applications, plus 3 CIPO patents and 4 EPO patents. Top assignees: Melior Pharmaceuticals I, Inc., Melior Discovery, Inc., Melior Pharmaceuticals Ii, LLC. Active years: 2010-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- West Chester, PA (US) (2014)
- Exton, PA (US) (2010 - 2024)
Company Filing History:
10 out of 13 
4 out of 4 
4 out of 4 Years Active: 2010-2026
Title: Michael S Saporito: Innovator in Kinase Modulation and Dyskinesia Treatment
Introduction
Michael S Saporito is a notable inventor based in Exton, PA (US), recognized for his contributions to the field of pharmaceutical innovations. He holds a total of 18 patents, showcasing his commitment to advancing medical science and treatment methodologies.
Latest Patents
Among his latest patents, Saporito has developed methods and formulations for modulating Lyn kinase activity and treating related disorders. This invention focuses on compounds and pharmaceutically acceptable salts that are effective in modulating Lyn kinase activity, which is crucial for treating various diseases such as cardiovascular disease, dyslipidemia, metabolic syndrome, type II diabetes, and more. Another significant patent involves methods of treating dyskinesia and related disorders, which describes compounds and formulations that aid in the treatment of these conditions.
Career Highlights
Saporito has worked with several companies, including Melior Pharmaceuticals Inc. and Melior Discovery Inc. His work in these organizations has contributed to the development of innovative treatments and therapies that address complex health issues.
Collaborations
Throughout his career, Saporito has collaborated with notable colleagues such as Andrew G Reaume and John Ciallella, enhancing the impact of his research and inventions.
Conclusion
Michael S Saporito's work exemplifies the spirit of innovation in the pharmaceutical industry. His patents and collaborations reflect a dedication to improving health outcomes through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile